1. Home
  2. SWTX

SWTX

SpringWorks Therapeutics Inc.

Logo SpringWorks Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

Founded: 2017 Country:
United States
United States
Employees: N/A City: STAMFORD
Market Cap: 3.2B IPO Year: 2019
Target Price: $66.60 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -5.15 EPS Growth: N/A
52 Week Low/High: $18.00 - $53.92 Next Earning Date: 05-01-2024
Revenue: $5,447,000 Revenue Growth: N/A
Revenue Growth (this year): 1535.47% Revenue Growth (next year): 193.46%

Share on Social Networks: